NCT06578598

Brief Summary

This study aims to compare the effectiveness and safety of two types of laryngeal masks- iGel and iGel Plus, used during elective surgeries. The focus is on evaluating differences in gastric insufflation and ventilation parameters between these two devices. Participants will be patients classified as ASA 1-2 with a BMI of less than 35, undergoing elective procedures. The study is designed as a prospective, randomized, controlled trial with 200 subjects divided evenly between the two laryngeal mask groups. Key outcomes include gastric cross-sectional area (CSA) measurements before and after surgery, ventilation metrics such as leakage pressure and PEEP, and the incidence of postoperative complications like nausea and respiratory issues.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for not_applicable surgery

Timeline
Completed

Started Oct 2024

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 20, 2024

Completed
9 days until next milestone

First Posted

Study publicly available on registry

August 29, 2024

Completed
1 month until next milestone

Study Start

First participant enrolled

October 1, 2024

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2025

Completed
Last Updated

August 29, 2024

Status Verified

August 1, 2024

Enrollment Period

1 year

First QC Date

August 20, 2024

Last Update Submit

August 27, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Crosssectional are of stomach

    Sonographic Measurement of gastric CSA

    5 minutes before anesthesia induction, during the surgery and 5 minutes after the surgery

Secondary Outcomes (3)

  • Ventilator Parameters

    during the surgery

  • Insertions of laryngeal mask

    during the induction of anesthesia (at the initiation of anesthesia)

  • postoperative complications

    after the surgery in recovery room

Study Arms (2)

Igel

SHAM COMPARATOR

Control device

Device: Igelplus

Igelplus

ACTIVE COMPARATOR

Study device

Device: Igelplus

Interventions

IgelplusDEVICE

Intubation with Igelplus laryngeal mask

IgelIgelplus

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with ASA classification 1-2
  • Undergoing elective surgery
  • Body Mass Index (BMI) \< 35
  • No contraindications for the laryngeal mask

You may not qualify if:

  • Presence of contraindications for the laryngeal mask
  • Urgent or non-elective surgeries

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
OTHER
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 20, 2024

First Posted

August 29, 2024

Study Start

October 1, 2024

Primary Completion

October 1, 2025

Study Completion

December 1, 2025

Last Updated

August 29, 2024

Record last verified: 2024-08